Erratum: Intranasal insulin ameliorates experimental diabetic neuropathy (Diabetes (2009) 58 (934-945) DOI: 10.2337/db08-1287);Intranasal insulin ameliorates experimental diabetic neuropathy

Diabetes

Volumn 58, Issue 4, 2009, Pages 934-945

  Francis, George ^a,b   Martinez, Jose ^a,b   Liu, Wei ^a,b   Nguyen, Thuhien ^c   Ayer, Amit ^a,b   Fine, Jared ^c   Zochodne, Douglas ^a,b   Hanson, Leah R ^c   Frey II, William H ^c,d   Toth, Cory ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c REGIONS HOSPITAL   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; IODINE 125; ISOPHANE INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLACEBO; PROTEIN KINASE B; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG TARGETING; EPIDERMIS; ISOTOPE LABELING; MALE; MORTALITY; MOUSE; NERVE FIBER DEGENERATION; NONHUMAN; PRIORITY JOURNAL; SCIATIC NERVE; SENSORY NERVE CONDUCTION; SIGNAL TRANSDUCTION; SPINAL GANGLION; STREPTOZOCIN DIABETES;

EID: 64649093418     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-rt05a     Document Type: Erratum

References (49)

1. Boulton AJ, Ward JD: Diabetic neuropathies and pain. Clin Endocrinol Metab 15:917-931, 1986
2. Zochodne DW: Diabetes mellitus and the peripheral nervous system: manifestations and mechanisms. Muscle Nerve 36:144-166, 2007
3. Smith AG, Ramachandran P, Tripp S, Singleton JR: Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology 57:1701-1704, 2001
4. Toth C, Brussee V, Cheng C, Zochodne DW: Diabetes mellitus and the sensory neuron. J Neuropathol Exp Neurol 63:561-573, 2004
5. Nelson D, Mah JK, Adams C, Hui S, Crawford S, Darwish H, Stephure D, Pacaud D: Comparison of conventional and non-invasive techniques for the early identification of diabetic neuropathy in children and adolescents with type 1 diabetes. Pediatr Diabetes 7:305-310, 2006
6. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
7. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
8. Calcutt NA, Freshwater JD, Mizisin AP: Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 47:718-724, 2004
9. Yamagishi S, Ogasawara S, Mizukami H, Yajima N, Wada R, Sugawara A, Yagihashi S: Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated-gamma- ligand, in insulin-deficient diabetic rats. J Neurochem 104:491-499, 2008
10. Pacher P, Obrosova IG, Mabley JG, Szabo C: Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem 12:267-275, 2005
11. Estrella JS, Nelson RN, Sturges BK, Vernau KM, Williams DC, LeCouteur RA, Shelton GD, Mizisin AP: Endoneurial microvascular pathology in feline diabetic neuropathy. Microvasc Res 75:403-410, 2008
12. Bierhaus A, Haslbeck KM, Humpert PM, Liliensiek B, Dehmer T, Morcos M, Sayed AA, Andrassy M, Schiekofer S, Schneider JG, Schulz JB, Heuss D, Neundörfer B, Dierl S, Huber J, Tritschler H, Schmidt AM, Schwaninger M, Haering Hu, Schleicher E, Kasper M, Stern DM, Arnold B, Nawroth PP: Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest 114:1741-1751, 2004
13. Toth C, Schmidt AM, Martinez JA, Song F, Ramji N, Brussee V, Liu W, Durand J, Rong LL, Zochodne DW: RAGE and experimental diabetic neuropathy. Diabetes 57:1002-1017, 2008
14. Calcutt NA, Jolivalt CG, Fernyhough P: Growth factors as therapeutics for diabetic neuropathy. Curr Drug Targets 9:47-59, 2008
15. Sima AA, Kamiya H: Diabetic neuropathy differs in type 1 and type 2 diabetes. Ann N Y Acad Sci 1084:235-249, 2006
16. Toth C, Brussee V, Martinez JA, McDonald D, Cunningham FA, Zochodne DW: Rescue and regeneration of injured peripheral nerve axons by intrathecal insulin. Neuroscience 139:429 -449, 2006
17. Toth C, Brussee V, Zochodne DW: Remote neurotrophic support of epidermal nerve fibres in experimental diabetes. Diabetologia 49:1081-1088, 2006
18. White MF, Yenush L: The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Curr Top Microbiol Immunol 228:179-208, 1998
19. Leinninger GM, Backus C, Uhler MD, Lentz SI, Feldman EL: Phosphatidyl-inositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons. FASEB J 18:1544-1546, 2004
20. Reger MA, Craft S: Intranasal insulin administration: a method for dissociating central and peripheral effects of insulin. Drugs Today (Barc) 42:729-739, 2006
21. Thorne RG, Pronk GJ, Padmanabhan V, Frey WH: Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127:481-496, 2004
22. Liu XF, Fawcett JR, Hanson LR, Frey WH: The window of opportunity for treatment of focal cerebral ischemic damage with noninvasive intranasal insulin-like growth factor-I in rats. JStroke Cerebrovasc Dis 13:16-23, 2004
23. Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B, Fishel MA, Plymate SR, Breitner JC, DeGroodt W, Mehta P, Craft S: Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology 70:440-448, 2008
24. Hargreaves K, Dubner R, Brown F, Flores C, Joris J: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia 630. Pain 32:77-88, 1988
25. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55-63, 1994
26. Sugimoto K, Murakawa Y, Sima AA: Expression and localization of insulin receptor in rat dorsal root ganglion and spinal cord. J Peripher Nerv Syst 7:44-53, 2002
27. Xu QG, Li XQ, Kotecha SA, Cheng C, Sun HS, Zochodne DW: Insulin as an in vivo growth factor. Exp Neurol 188:43-51, 2004
28. Fernyhough P, Willars GB, Lindsay RM, Tomlinson DR: Insulin and insulin-like growth factor I enhance regeneration in cultured adult rat sensory neurones. Brain Res 607:117-124, 1993
29. Zochodne DW, Verge VM, Cheng C, Sun H, Johnston J: Does diabetes target ganglion neurones? Progressive sensory neurone involvement in long-term experimental diabetes. Brain 124:2319-2334, 2001
30. Mahadev K, Wu X, Motoshima H, Goldstein BJ: Integration of multiple downstream signals determines the net effect of insulin on MAP kinase vs. PI 3'-kinase activation: potential role of insulin-stimulated H(2)O(2) 7. Cell Signal 16:323-331, 2004
31. Huang TJ, Verkhratsky A, Fernyhough P: Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons. Mol Cell Neurosci 28:42-54, 2005
32. Huang TJ, Price SA, Chilton L, Calcutt NA, Tomlinson DR, Verkhratsky A, Fernyhough P: Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 52:2129-2136, 2003
33. Fernyhough P, Huang TJ, Verkhratsky A: Mechanism of mitochondrial dysfunction in diabetic sensory neuropathy. J Peripher Nerv Syst 8:227-235, 2003
34. Bruss MD, Arias EB, Lienhard GE, Cartee GD: Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity. Diabetes 54:41-50, 2005
35. Yao R, Cooper GM: Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267:2003-2006, 1995
36. Viard P, Butcher AJ, Halet G, Davies A, Nurnberg B, Heblich F, Dolphin AC: PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane. Nat Neurosci 7:939-946, 2004
37. Jones DM, Tucker BA, Rahimtula M, Mearow KM: The synergistic effects of NGF and IGF-1 on neurite growth in adult sensory neurons: convergence on the PI 3-kinase signaling pathway. J Neurochem 86:1116-1128, 2003
38. Ogata T, Iijima S, Hoshikawa S, Miura T, Yamamoto S, Oda H, Nakamura K, Tanaka S: Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination. J Neurosci 24:6724-6732, 2004
39. Maurel P, Salzer JL: Axonal regulation of Schwann cell proliferation and survival and the initial events of myelination requires PI 3-kinase activity. J Neurosci 20:4635-4645, 2000
40. Liang G, Cline GW, Macica CM: IGF-1 stimulates de novo fatty acid biosynthesis by Schwann cells during myelination. Glia 55:632-641, 2007
41. Zheng WH, Kar S, Quirion R: Insulin-like growth factor-1-induced phosphorylation of transcription factor FKHRL1 is mediated by phosphatidylinositol 3-kinase/Akt kinase and role of this pathway in insulin-like growth factor-1-induced survival of cultured hippocampal neurons. Mol Pharmacol 62:225-233, 2002
42. Walton M, Woodgate AM, Muravlev A, Xu R, During MJ, Dragunow M: CREB phosphorylation promotes nerve cell survival. J Neurochem 73: 1836-1842, 1999
43. Lonze BE, Riccio A, Cohen S, Ginty DD: Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB. Neuron 34:371-385, 2002
44. Hetman M, Cavanaugh JE, Kimelman D, Xia Z: Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. J Neurosci 20:2567-2574, 2000
45. Pap M, Cooper GM: Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J Biol Chem 273:19929-19932, 1998
46. Cohen P, Frame S: The renaissance of GSK3. Nat Rev Mol Cell Biol 2:769-776, 2001
47. Grimes CA, Jope RS: CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem 78:1219-1232, 2001
48. Tomlinson DR, Gardiner NJ: Glucose neurotoxicity. Nat Rev Neurosci 9:36-45, 2008
49. Kennedy JM, Zochodne DW: Experimental diabetic neuropathy with spontaneous recovery: is there irreparable damage? Diabetes 54:830-837, 2005